Mulya Raya Petra Sejahtera is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Timur. The company was founded in 2009. Mulya Raya Petra Sejahtera is a prominent player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The primary business line of Mulya Raya Petra Sejahtera is the production of generic and branded pharmaceuticals, catering to various therapeutic areas such as cardiovascular, anti-infectives, and over-the-counter medications. The company also engages in secondary activities, including research and development of new drug formulations and healthcare solutions. Mulya Raya Petra Sejahtera operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Bandung. The company has established a robust distribution network to ensure the availability of its products nationwide. Internationally, Mulya Raya Petra Sejahtera has expanded its footprint by exporting its products to several countries in Southeast Asia, including Malaysia, Thailand, and the Philippines. The company is actively seeking partnerships and joint ventures with international pharmaceutical firms to enhance its product offerings and market reach. As a member of various pharmaceutical associations, Mulya Raya Petra Sejahtera is committed to adhering to global standards of quality and safety in its operations. The company's vision is to become a leading pharmaceutical company in the region, dedicated to innovation and excellence in healthcare solutions.
Headquarters
Kota Surabaya Mojo Gubeng Jawa Timur
Surabaya; East Java;
Postal Code: 60285
Contact Details: Purchase the PT Mulya Raya Petra Sejahtera report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service